Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART-Reference-Cited by-同舟云学术

Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART

Published:2010-11-11 Issue:11 Volume:5 Page:e13540
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ensoli Barbara,Bellino Stefania,Tripiciano Antonella,Longo Olimpia,Francavilla Vittorio,Marcotullio Simone,Cafaro Aurelio,Picconi Orietta,Paniccia Giovanni,Scoglio Arianna,Arancio Angela,Ariola Cristina,Ruiz Alvarez Maria J.,Campagna Massimo,Scaramuzzi Donato,Iori Cristina,Esposito Roberto,Mussini Cristina,Ghinelli Florio,Sighinolfi Laura,Palamara Guido,Latini Alessandra,Angarano Gioacchino,Ladisa Nicoletta,Soscia Fabrizio,Mercurio Vito S.,Lazzarin Adriano,Tambussi Giuseppe,Visintini Raffaele,Mazzotta Francesco,Di Pietro Massimo,Galli Massimo,Rusconi Stefano,Carosi Giampiero,Torti Carlo,Di Perri Giovanni,Bonora Stefano,Ensoli Fabrizio,Garaci Enrico

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference104 articles.

1. The survival benefits of AIDS treatment in the United States.;RP Walensky;J Infect Dis,2006

2. Immune activation and inflammation in HIV-1 infection: causes and consequences.;V Appay;J Pathol,2008

3. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.;SG Deeks;BMJ,2009

4. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.;CF Kelley;Clin Infect Dis,2009

5. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.;GK Robbins;Clin Infect Dis,2009

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis;International Journal of Molecular Sciences;2024-01-30

2. HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine;Expert Review of Vaccines;2022-06-17

3. Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies;Current Drug Delivery;2022-01

4. Gene-specific MicroRNA antagonism protects against HIV Tat and TGF-β-mediated suppression of CFTR mRNA and function;Biomedicine & Pharmacotherapy;2021-10

5. New insights into pathogenesis point to HIV-1 Tat as a key vaccine target;Archives of Virology;2021-08-14